A
Approxima
Health Tech & Medtech · Milan, Italy · Founded 2020
The first minimally invasive treatment tailored for the tricuspid valve MoreLess
Approxima Medical is a forward-thinking company specializing in the development of advanced medical technologies aimed at improving patient care and treatment outcomes. Focused on precision and innovation, Approxima Medical integrates cutting-edge technology with clinical expertise to create solutions that address complex medical challenges.
Their offerings include a range of sophisticated devices and systems designed to enhance diagnostic accuracy, streamline treatment processes, and support healthcare professionals in delivering optimal care. By leveraging state-of-the-art technology and a deep understanding of clinical needs, Approxima Medical aims to transform the landscape of modern medicine.
Committed to advancing healthcare, Approxima Medical emphasizes research and development to bring groundbreaking solutions to market. Their products are crafted to meet the highest standards of quality and performance, ensuring that they provide significant benefits to both patients and healthcare providers.
Through their innovative approach, Approxima Medical is dedicated to making a meaningful impact on patient health and the efficiency of healthcare systems, striving to deliver technologies that improve outcomes and elevate the standard of care.
Talent graph
Approxima's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Approxima has talent and traffic
team presence
Market sentiment
What the market is saying about Approxima
An AI-synthesized read of the highest-engagement posts about Approxima on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Approxima on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.



